1. Home
  2. STWD vs BIO Comparison

STWD vs BIO Comparison

Compare STWD & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STWD
  • BIO
  • Stock Information
  • Founded
  • STWD 2009
  • BIO 1952
  • Country
  • STWD United States
  • BIO United States
  • Employees
  • STWD N/A
  • BIO N/A
  • Industry
  • STWD Real Estate Investment Trusts
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • STWD Real Estate
  • BIO Industrials
  • Exchange
  • STWD Nasdaq
  • BIO Nasdaq
  • Market Cap
  • STWD 7.4B
  • BIO 7.7B
  • IPO Year
  • STWD 2009
  • BIO N/A
  • Fundamental
  • Price
  • STWD $18.81
  • BIO $303.22
  • Analyst Decision
  • STWD Buy
  • BIO Strong Buy
  • Analyst Count
  • STWD 4
  • BIO 4
  • Target Price
  • STWD $21.13
  • BIO $333.50
  • AVG Volume (30 Days)
  • STWD 3.1M
  • BIO 214.4K
  • Earning Date
  • STWD 11-05-2025
  • BIO 10-29-2025
  • Dividend Yield
  • STWD 10.15%
  • BIO N/A
  • EPS Growth
  • STWD N/A
  • BIO N/A
  • EPS
  • STWD 1.09
  • BIO 11.49
  • Revenue
  • STWD $342,354,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • STWD $362.88
  • BIO $2.12
  • Revenue Next Year
  • STWD $3.45
  • BIO $2.90
  • P/E Ratio
  • STWD $17.33
  • BIO $25.93
  • Revenue Growth
  • STWD N/A
  • BIO N/A
  • 52 Week Low
  • STWD $16.59
  • BIO $211.43
  • 52 Week High
  • STWD $21.05
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • STWD 23.88
  • BIO 56.19
  • Support Level
  • STWD $19.24
  • BIO $266.71
  • Resistance Level
  • STWD $19.57
  • BIO $311.43
  • Average True Range (ATR)
  • STWD 0.22
  • BIO 8.41
  • MACD
  • STWD -0.13
  • BIO 2.08
  • Stochastic Oscillator
  • STWD 0.00
  • BIO 66.08

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment, and Investing & Servicing Segment. The company generates the majority of its revenue from the Commercial and Residential Lending Segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: